| ||||||||||||||||||||||
| ||||||||||||||||||||||
Entries tagged "pharmaceuticals"What will be the next Big Pharma deal?There's been quite a bit of M&A activity in the pharma world lately. What companies within the sector will likely be the next to be acquired? Sullivan & Cromwell's Pagnani on biotech M&AAt The Deal LLC's Healthcare Dealmaking Symposium, attorney Keith Pagnani commented on how the dealmaking landscape for biotechs is changing. Here comes pharma's 'me-too' mergersThe pharmaceutical industry is notorious for creating copycat drugs. Now Pfizer's $68 billion bid for Wyeth could prompt Merck, Sanofi-Aventis and other peers to launch 'me-too' mergers. Deal Stocks: Pharmas get shot in the armDeal news from PharmaNet and Amylin gave pharmaceutical stocks a boost on Tuesday. Genentech stays mum on Roche bidGenentech Inc. reported third-quarter earnings late Tuesday. Thanks to its cancer drugs, the news was generally good for the biotech giant. But conference call participants interested in deal news weren't satisfied because Genentech management refused to comment on the progress of the proposed takeover by Roche AG, Genentech's majority owner, which has moved to buy out the 44% it doesn't own for $89 a share. ... Pharma-related Deal Stocks need shot in the armA smattering of deal news across pharmaceutical-related stocks, whether it be pharmacy retailers or drug companies, did little to boost their shares as the broader market ended a volatile week on a not-so-volatile note. The Dow Jones Industrial Average inched down 11.72 points to close at 11,421.99. ... Report of Teva offer sparks Stada stockShares of German generic pharmaceutical company Stada Arzneimittel AG received a shot in the arm Friday amid a report generics giant Teva Pharmaceuticals Industries Ltd. was considering an offer.... Novartis to acquire VC-backed ProtezDrugs giant Novartis AG said Wednesday it has agreed to acquire venture capital-backed Protez Pharmaceuticals Inc., including the rights to a novel antibiotic, for up to $400 million. ... Biopharma deals dragged down growth in '07Accounting firm Ernst & Young released Tuesday its yearly biotech industry survey, "Beyond Borders," and it has some interesting deal-related tidbits. For one, M&A in the sector helped tamp down overall revenue growth, according to E&Y. ... Dealwatch: TakedaA single shareholder is trying to stop Japanese drug giant Takeda Pharmaceutical Co. Ltd.'s latest deal in its tracks by bringing suit to thwart the company's planned $8.8 billion takeover of Millennium Pharmaceuticals Inc.... FTC's David Wales on mergers in healthcareDavid P. Wales Jr., deputy director of the Federal Trade Commission's Bureau of Competition, discussed how the FTC evaluates hospital mergers and pharmaceutical mergers and its ongoing investigations at The Deal's Healthcare Dealmaking Symposium. - Maria Woehr... Deal Stocks make healthy gainsAlthough presidential contenders are talking about some major remedies to the ailing healthcare system, SXC Health Solutions Corp., Humana Inc. and CollaGenex Pharmaceutical Inc. announced middle-market deals that sent shares up in midday trading Tuesday. The Dow was up 118.04, or 0.94% to 12,688.26 while the Nasdaq inched up 24.52, or 1.05% to 2,352.00.... Top tagsYou have executed a tag search on Dealscape. On the left,you will find a comprehensive list of stories tagged "pharmaceuticals." Below are the most-popular tags for Dealscape. On the right of the page you will find a search box to dig deeper into our content.
 Deal Video
    Community
 Elsewhere on The Deal.comDealwatch
The Deal MagazineCorporate Dealmaker
The Deal VideoCategories
Blog roll
Archives
| ||||||||||||||||||||||
| ||||||||||||||||||||||
